|
Volumn 41, Issue 2, 2003, Pages 153-162
|
Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
HUMALOG MIX25;
INSULIN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
DRUG EFFECT;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
INJECTION;
MALE;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PATIENT SATISFACTION;
POSTPRANDIAL STATE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INJECTIONS;
INSULIN;
MALE;
MIDDLE AGED;
PATIENT SATISFACTION;
POSTPRANDIAL PERIOD;
TREATMENT OUTCOME;
|
EID: 16544375351
PISSN: 12204749
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|